Atlas Trials

Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder

Clinical trial NCT02611921 · COMPLETED

Trial details

NCT number
NCT02611921
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2015-12-22
Primary completion
2018-05-07
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.